Individuals who have conducted quality assessments of guidelines are encouraged to send us their assessment so that the information can be added to this website. Please email martin.drapeau [at] mcgill.ca (subject: PSY%2B%20Guidelines) (Dr. Martin Drapeau).
Most of the guidelines below have been assessed using the Appraisal of Guidelines for Research & Evaluation II (AGREE-II) tool, which is generally considered to be the gold standard tool for guideline quality assessment. When another scale was used, this is reported in the Summary column of each table.
AGREE-II consists of 23 items organized within 6 domains, each capturing a unique dimension of guideline quality:
- Domain 1. Scope and Purpose is concerned with the overall aim of the guideline, the specific health questions, and the target population (items 1-3)
- Domain 2. Stakeholder Involvement focuses on the extent to which the guideline was developed by the appropriate stakeholders and represents the views of its intended users (items 4-6).
- Domain 3. Rigour of Development relates to the process used to gather and synthesize the evidence, the methods to formulate the recommendations, and to update them (items 7-14).
- Domain 4. Clarity of Presentation deals with the language, structure, and format of the guideline (items 15-17).
- Domain 5. Applicability pertains to the likely barriers and facilitators to implementation, strategies to improve uptake, and resource implications of applying the guideline items (items 18-21).
- Domain 6. Editorial Independence is concerned with the formulation of recommendations not being unduly biased with competing interests (items 22-23).
Learn more about AGREE-II by watching an introductory video in our section on Evaluating Guidelines, or visit the AGREEtrust website. Recommendations for the use of a guideline are proposed based on the following criteria:
- Use: Scores above 60% in all domains
- Use with caution: Scores below 60% in one or more domains
- Use with great caution: Scores below 60% on Domain 3
- Do not use: Scores below 60% in all domains
These cut-offs are suggestions only. Policy makers and practitioners are required to use their judgement in deciding if the use of a guideline is warranted. While the summaries below may give practitioners some insight into the methodological quality of a guideline, we make no claim as to the utility or value of any of the guidelines listed below.
Adolescents in Court
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| psychoeducational evaluation; youth tribunal; Youth Criminal Justice Act; court | Lignes directrices sur l'évaluation d'un adolescent dans le cadre d'une décision du tribunal en application de la Loi sur le système de justice pénale pour les adolescents (2014) | Ordre des psychoéducateurs et psychoéducatrices du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 70% for scope and purpose,60% for stakeholder involvement,3% for rigour of development,40% for clarity of presentation,3% for applicability, and0% for editorial independence. | Use with great caution |
Anticipation of Incapacity
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| psychosocial assessment; incapacity; adults | Évaluation psychosociale dans le contexte des régimes de protection, du mandat donné en prévision de l'inaptitude et des autres mesures de protection au majeur (2011) | Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 94% for scope and purpose, 57% for stakeholder involvement, 13% for rigour of development, 97% for clarity of presentation, 50% for applicability, and 0% for editorial indepdence. | Use with great caution |
Antidepressant Treatment for Depression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| adults mainly; treatment using anti-depressants | Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines (2015) | British Association for Psychopharmacology (U.K.) |
The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 83% for scope and purpose, 56% for stakeholder involvement, 55% for rigour of development, 78% for clarity of presentation, 13% for applicability, and 83% for editorial independence. The guideline was also assessed by another team consisting of 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 58.3% for scope and purpose, 50% for stakeholder involvement, 36.5% for rigour of development, 75% for clarity of presentation, 8.3% for applicability, and 58.3% for editorial independence. |
Use with great caution |
Antisocial Behaviour and Conduct Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; prevention; assessment; psychosocial treatment; pharmacological treatment | Antisocial behaviour and conduct disorders in children and young people: Recognition and management—Tools and resources (2013) | National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 97.2% for scope and purpose, 94.4% for stakeholder involvement, 81.3% for rigour of development, 86.1% for clarity of presentation, 81.3% for applicability, and 95.8% for editorial independence. | Use |
| antisocial behaviour; conduct disorders; children; adolescents; assessment; prevention; treatment | Antisocial behaviour and conduct disorders in children and young people: Recognition and management—Supporting evidence (2013) | National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 100% for scope and purpose, 100% for stakeholder involvement, 83.3% for rigour of development, 94.4% for clarity of presentation, 64.6% for applicability, and 91.7% for editorial independence. | Use |
Anxiety Disorders
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; assessment; treatment | Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders (2007) | Connolly, S. D., Bernstein G. A. & Work Group on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46(2), 267 (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 41.7% for scope and purpose, 22.2% for stakeholder involvement, 31.3% for rigour of development, 58.3% for clarity of presentation, 4.2% for applicability, and 20.8% for editorial independence. | Do not use |
| diagnosis; management; intervention; treatment | Clinical Practice Guidelines for the Management of Anxiety Disorders (2006) | Canadian Psychiatric Association (Canada) | The guideline was assessed by three trained Master-level researchers using the AGREE-II scale (see Middleton, J. C., Kalogeropoulos, C., Middleton, J. A., & Drapeau, M. (2018). Assessing the methodological quality of the Canadian Psychiatric Associations anxiety and depression clinical practice guidelines. Journal of Evaluation in Clinical Practice. doi:10.1111/jep.13026). The guideline obtained a score of 91% for scope and development, 46% for stakeholder involvement, 60% for rigour of development, 78% for clarity of presentation, 35% for applicability, and 36% for editorial independence. | Use with caution |
| general population; pharmacological treatment | Evidence‐based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology (2005) | Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R., … Wittchen, H.‐U. (2005). Evidence‐based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 19(6), 567–596. (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 69.4% for scope and purpose, 63.9% for stakeholder involvement, 32.3% for rigour of development, 63.9% for clarity of presentation, 8.3% for applicability, and 16.7% for editorial independence. | Use with great caution |
Anxiety, Posttraumatic Stress, and Obsessive Compulsive Disorders
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| anxiety; PTSD; OCD; general population; diagnosis; treatment | Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive‐compulsive disorders (2014) | Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., … Walker, J. R. (2014). Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive‐compulsive disorders. BMC Psychiatry, 14(Suppl 1), S1. (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 47.2% for scope and purpose, 50% for stakeholder involvement, 39.6% for rigour of development, 33.3% for clarity of presentation, 4.2% for applicability, and 45.8% for editorial independence. | Do not use |
Assessment of Mental or Neuropsychological Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| evaluation; mental disorder; neuropsychological disorder | Évaluer une personne ayant un trouble mental ou neuropsychologique attesté par un diagnostic par une évaluation effectuée par un professionnel habilité (2011) | Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 94% for scope and purpose, 63% for stakeholder involvement, 20% for rigour of development, 82% for clarity of presentation, 23% for applicability, and 0% for editorial independence. | Use with great caution |
Attention Deficit Hyperactivity Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; sleeping problems; assessment; children and adolescents; pharmacological treatment; behavioural treatment | Assessment and Management of Sleep Problems in Youths With Attention-Deficit/Hyperactivity Disorder (2013) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 47.2% for scope and purpose, 25% for stakeholder involvement, 33.3% for rigour of development, 75% for clarity of presentation, 6.3% for applicability, and 50% for editorial independence. | Use with great caution | |
| ADHD; children; adolescents; young adults; diagnosis; pharmacological treatment; non-pharmacological treatment; comorbidity; resources | Attention-deficit hyperactivity disorder: Guidelines for clinical care (2013) | University of Michigan Health System (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 41.7% for scope and purpose, 27.8% for stakeholder involvement, 25% for rigour of development, 63.9% for clarity of presentation, 37.5% for applicability, and 29.2% for editorial independence. | Use with great caution |
| ADHD; children; adolescents; diagnosis; assessment; pharmacological treatment; psychological treatment; educational management | Clinical practice points on the diagnosis, assessment and management of attention deficit hyperactivity disorder in children and adolescents (2012) | National Health and Medical Research Council (Australia) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 58.3% for scope and purpose, 80.6% for stakeholder involvement, 37.5% for rigour of development, 80.6% for clarity of presentation, 4.2% for applicability, and 75% for editorial independence. | Use with great caution |
| ADHD; children; adolescents; diagnosis; assessment; treatment | ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents (2011) | American Academy of Pediatrics (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 86.1% for scope and purpose, 63.9% for stakeholder involvement, 62.5% for rigour of development, 97.2% for clarity of presentation, 50% for applicability, and 62.5% for editorial independence. | Use with caution |
| ADHD; children; adolescents; adults; diagnosis; management; psychosocial treatment; pharmacological treatment | Canadian ADHD Practice Guidelines (3rd ed.) (2011) | Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 50% for scope and purpose, 50% for stakeholder involvement, 26% for rigour of development, 44.4% for clarity of presentation, 27.1% for applicability, and 66.7% for editorial independence. | Use with great caution |
| ADHD; medication side-effects; children; management of side-effects | European guidelines on managing adverse effects of medication for ADHD (2011) | Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., … Taylor, E. (2011). European guidelines on managing adverse effects of medication for ADHD. European Child & Adolescent Psychiatry, 20(1), 17–37. https://doi.org/10.1007 /s00787-010-0140-6. (Europe) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 47.2% for scope and purpose, 33.3% for stakeholder involvement, 17.7% for rigour of development, 41.7% for clarity of presentation, 4.2% for applicability, and 29.2% for editorial independence. | Do not use |
| ADHD; children; adolescents; diagnosis; assessment; treatment | Clinical Practice Guideline on Attention Defi cit Hyperactivity Disorder (ADHD) in Children and Adolescents (2010) | Guia Salud (Spain) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 97.2% for scope and purpose, 77.8% for stakeholder involvement, 76% for rigour of development, 88.9% for clarity of presentation, 52.1% for applicability, and 79.2% for editorial independence. | Use with caution |
| ADHD; children; adolescents; diagnosis; assessment; treatment | Management of attention deficit and hyperkinetic disordersin children and young people (2009) | Scottish Intercollegiate Guidelines Network (Scotland) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 72.2% for scope and purpose, 55.6% for stakeholder involvement, 65.6% for rigour of development, 83.3% for clarity of presentation, 52.1% for applicability, and 50% for editorial independence. | Use with caution |
| ADHD; children; adolescents; assessment; psychopharmacological treatment; psychosocial treatment | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (2007) | Pliszka, S. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46(7), 894–921. https://doi.org/10.1097/c (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 52.8% for scope and purpose, 33.3% for stakeholder involvement, 34.3% for rigour of development, 75% for clarity of presentation, 8.3% for applicability, and 16.7% for editorial independence. | Use with great caution |
| ADHD; children; diagnosis; treatment | Global consensus on ADHD/HKD (2005) | Remschmidt, H. (2005). Global consensus on ADHD/HKD. European Child & AdolescentPsychiatry, 14(3), 127–137. https://doi.org/10.1007/ s00787-005-0439-x. (Global) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 36.1% for scope and purpose, 16.7% for stakeholder involvement, 9.4% for rigour of development, 69.4% for clarity of presentation, 12.5% for applicability, and 33.3% for editorial independence. | Use with great caution |
| ADHD; children; adolescents; diagnosis; assessment; treatment | Academy of Medicine-Ministry of Health Clinical Practice Guidelines: Attention Deficit Hyperactivity Disorder (2014) | Fung, D. S., Lim, C. G., Wong, J. C., Ng, K. H., Cheok, C. C., Kiing, J. S., … Low, C. (2014). Academy of Medicine-Ministry of Health clinical practice guidelines: Attention deficit hyperactivity disorder. Singapore Medical Journal, 55(8), 411–414. (Singapore) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 80.6% for scope and purpose, 72.2% for stakeholder involvement, 42.7% for rigour of development, 75% for clarity of presentation, 22.9% for applicability, and 8.3% for editorial independence. | Use with great caution |
| ADHD; children; adolescents; diagnosis; risk factors; assessment; intervention; pharmacological treatment | Attention-deficit/hyperactivity disorder (ADHD) in Children and Adolescents (2011) | University of Arkansas for Medical Sciences - Psychiatric Research Institute (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 8.3% for scope and purpose, 8.3% for stakeholder involvement, 5.2% for rigour of development, 52.8% for clarity of presentation, 16.7% for applicability, and 16.7% for editorial independence. | Do not use |
| ADHD; children; adolescents; pharmacological treatment; side-effect management | Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents (2013) | Cortese, S., et al. (2013). Practitioner review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. Journal of Child Psychology and Psychiatry, 54(3), 227–246. (Europe) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 66.7% for scope and purpose, 50% for stakeholder involvement, 47.9% for rigour of development, 86.1% for clarity of presentation, 8.3% for applicability, and 66.7% for editorial independence. | Use with great caution |
| ADHD; children; adults; treatment; physiological model of ADHD | Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology (2014) | Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., … Young, S. J. (2014). Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 52.8% for scope and purpose, 69.4% for stakeholder involvement, 34.4% for rigour of development, 66.7% for clarity of presentation, 6.3% for applicability, and 66.7% for editorial independence. | Use with great caution |
| ADHD; aggression; children; adolescents; treatment of aggression; care recommendations | Evidence-Based Recommendations for the Treatment of Aggression in Pediatric Patients with Attention Deficit Hyperactivity Disorder (2011) | List, B. A., & Barzman, D. H. (2011). Evidence-based recommendations for the treatment of aggression in pediatric patients with attention deficit hyperactivity disorder. Psychiatric Quarterly, 82(1), 33–42. https://doi.org/10.1007/ s11126-010-9145-z. (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 94.4% for scope and purpose, 38.9% for stakeholder involvement, 46.9% for rigour of development, 72.2% for clarity of presentation, 14.6% for applicability, and 0% for editorial independence. | Use with great caution |
Attention Deficit Hyperactivity Disorder - Transition to Adult Services
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; adolescents; transition to adulthood; adults; diagnosis; assessment; treatment | Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: Recommendations from the British Association for Psychopharmacology (2007) | Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., … Young, S. (2007). Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 21(1), 10–41. https://doi.org/10.1177/ 0269881106073219. (U.K.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 52.8% for scope and purpose, 47.2% for stakeholder involvement, 36.5% for rigour of development, 83.3% for clarity of presentation, 25% for applicability, and 54.2% for editorial independence. | Use with great caution |
Attention Deficit Hyperactivity Disorder and Aggression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; aggression; children; adolescents; treatment of aggression; care recommendations | Evidence-Based Recommendations for the Treatment of Aggression in Pediatric Patients with Attention Deficit Hyperactivity Disorder (2011) | List, B. A., & Barzman, D. H. (2011). Evidence-based recommendations for the treatment of aggression in pediatric patients with attention deficit hyperactivity disorder. Psychiatric Quarterly, 82(1), 33–42. https://doi.org/10.1007/s11126-010-9145-z. (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 94.4% for scope and purpose, 38.9% for stakeholder involvement, 46.9% for rigour of development, 72.2% for clarity of presentation, 14.6% for applicability, and 0% for editorial independence. | Use with great caution |
Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder Comorbidity
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; ASD; children; adolescents; evaluation; pharmacological treatment | Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders (2012) | Mahajan, R., Bernal, M. P., Panzer, R., Whitaker, A., Roberts, W., Handen, B., … Veenstra-VanderWeele, J. (2012). Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders. Pediatrics, 130(Supplement 2), S125–S138. https://doi.org/10.1542 /peds.2012-0900J. (U.S.A./Canada) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 66.7% for scope and purpose, 38.9% for stakeholder involvement, 50% for rigour of development, 77.8% for clarity of presentation, 10.4% for applicability, and 25% for editorial independence. | Use with great caution |
Autism Spectrum Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| evaluation; children; adolescents; young adults | Lignes directrices sur l'évaluation clinique des troubles du spectre de l'autisme (2012) or Practice Guidelines for the Clinical Evaluation of Autism Spectrum Disorder (2012) | Ordre des Psychologues du Québec (Canada) |
The guideline was assessed by a research team from the Science and Practice in Psychology Research Group trained using the AGREE-II scale (Unpublished data). The guideline obtained a score of 100% for scope and purpose, 43% for stakeholder involvement, 10% for rigour of development, 67% for clarity of presentation, 18% for applicability, and 56% for editorial independence. The guideline was also assessed by another team consisting of 4 trained assessors from the Science and Practice in Psychology Research Group using a method derived from Ansari & Rachidian (2012) (see Stamoulos, C., Reyes, A., Trepanier, L., & Drapeau, M. (2014). The methodological quality of clinical practice guidelines in psychology: A pilot study of the guidelines developed by the Ordre des Psychologues du Québec. Canadian Psychology/Psychologie Canadienne, 55(3), 177–186. doi: 10.1037/a0037287). The guideline was found to not meet the minimum quality requirements for the 27 tasks related to proper guideline development. |
Use with great caution |
Auto-insurance Claims
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| assessment; treatment | Guidelines for Assessment and Treatment in Auto Insurance Claims (2010) | Ontario Psychological Association (OPA) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 100% for scope and purpose, 67% for stakeholder involvement, 54% for rigour of development, 78% for clarity of presentation, 83% for applicability, and 0% for editorial independence. | Use with great caution |
Behaviour Disorders
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; ODD, CD; children; adolescents; pharmacotherapy | Canadian Guidelines on Pharmacotherapy for Disruptive and Aggressive Behaviour in Children and Adolescents With Attention-Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, or Conduct Disorder (2015) | Gorman, D. A., Gardner, D. M., Murphy, A. L., Feldman, M., Belanger, S. A., Steele, M. M., … Pringsheim, T. (2015). Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder. Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie, 60(2), 62–76. (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 94.4% for scope and purpose, 63.9% for stakeholder involvement, 72.9% for rigour of development, 72.2% for clarity of presentation, 2.1% for applicability, and 75% for editorial independence. | Use with caution |
Child Custody and Access Rights
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| expert witness; child custody; access rights; process; ethics | Lignes directrices pour l'expertise en matière de garde d'enfants et des droits d'accès (2006) or Guidelines for Expert Assessment Concerning Child Custody and Access Rights (2006) |
Ordre des Psychologues du Québec (Canada) and Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) |
The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 54% for scope and purpose,25% for stakeholder involvement,3% for rigour and development,61% for clarity of presentation,11% for applicability, and0% for editorial independence. The guideline was also assessed by another team consisting of 4 trained assessors from the Science and Practice in Psychology Research Group using a method derived from Ansari & Rachidian (2012) (see Stamoulos, C., Reyes, A., Trepanier, L., & Drapeau, M. (2014). The methodological quality of clinical practice guidelines in psychology: A pilot study of the guidelines developed by the Ordre des Psychologues du Québec. Canadian Psychology/Psychologie Canadienne, 55(3), 177–186. doi: 10.1037/a0037287). The guideline was found to not meet the minimum quality requirements for the 27 tasks related to proper guideline development. |
Use with great caution |
Child Custody and Protection
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| psychological services; child custody disputes; child protection proceedings; therapy; assessments; mental health consultations | Information for Consideration by Members Providing Psychological Services in the Context of Child Custody Disputes & Child Protection Proceedings (2014) | College of Psychologists of Ontario (CPO) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 100% for scope and purpose, 61% for stakeholder involvement, 21% for rigour of development, 83% for clarity of presentation, 29% for applicability, and 0% for editorial independence. | Use with great caution |
Comparative Treatment of Major Depressive Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| adults; pharmacological and non-pharmacological comparative treatment | Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians (2016) | American College of Physicians (U.S.A.) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 100% for scope and purpose, 89% for stakeholder involvement, 88% for rigour of development, 72% for clarity of presentation, 0% for applicability, and 100% for editorial independence. | Use with caution |
Conduct Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| Conduct disorder guideline (2015)* | Ministry of Social Development (New Zealand) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 69.4% for scope and purpose, 25% for stakeholder involvement, 7.3% for rigour of development, 38.9% for clarity of presentation, 10.4% for applicability, and 4.6% for editorial independence. | Use with great caution |
Depression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| adolescents; management; treatment | Guidelines for Adolescent Depression in Primary Care (GLAD‐PC): II. Treatment and ongoing management (2007) | Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., Stein, R. E. and the GLAD‐PC Steering Group. (2007). Guidelines for Adolescent Depression in Primary Care (GLAD‐PC): II. Treatment and ongoing management. Pediatrics, 120(5), e1313–1326. https://doi.org/10.1542/peds.2006-1395 (Canada and U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 61.1% for scope and purpose, 66.7% for stakeholder involvement, 51% for rigour of development, 80.6% for clarity of presentation, 37.5% for applicability, and 50% for editorial independence. | Use with great caution |
| adults; treatment; psychotherapy; medication | The long-term efficacy of psychotherapy, alone or in combination with antidepressants in the treatment of adult major depression (2014) | Karyotaki, E., Smit, Y., Cuijpers, P., Debauche, M., de Keyser, T., Habraken, H., … Holdt Henningsen, K. (2014). The long-term efficacy of psychotherapy, alone or in combination with antidepressants in the treatment of adult major depression. Clinical Psychology. (Belgium) | The guideline was assessed by 3 trained post-graduate level appraisers using the AGREE-II scale (see Medina, J. C., Schmelefske, E., Hébert, C., & Drapeau, M. (2020). European clinical practice guidelines for depression in adults: Are they good enough? Journal of Affective Disorders, 263, 382–385. doi: 10.1016/j.jad.2019.12.005). The guideline obtained a score of 100% for scope and purpose, 91% for stakeholder involvement, 90% for rigour of development, 83% for clarity of presentation, 42% for applicability, and 89% for editorial independence. | Use with caution |
| adults; assessment; treatment | Depression in adults: recognition and management (2009) | National Collaborating Centre for Mental Health; National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 3 trained post-graduate level appraisers using the AGREE-II scale (see Medina, J. C., Schmelefske, E., Hébert, C., & Drapeau, M. (2020). European clinical practice guidelines for depression in adults: Are they good enough? Journal of Affective Disorders, 263, 382–385. doi: 10.1016/j.jad.2019.12.005). The guideline obtained a score of 100% for scope and purpose, 96% for stakeholder involvement, 91% for rigour of development, 98% for clarity of presentation, 79% for applicability, and 67% for editorial independence. | Use |
| adults; treatment | Clinical practice guideline on the management of major depression in adults (2014) | Working group of the "clinical practice guideline on the management of depression in adults" (Spain) | The guideline was assessed by 3 trained post-graduate level appraisers using the AGREE-II scale (see Medina, J. C., Schmelefske, E., Hébert, C., & Drapeau, M. (2020). European clinical practice guidelines for depression in adults: Are they good enough? Journal of Affective Disorders, 263, 382–385. doi: 10.1016/j.jad.2019.12.005). The guideline obtained a score of 100% for scope and purpose, 91% for stakeholder involvement, 71% for rigour of development, 98% for clarity of presentation, 65% for applicability, and 67% for editorial independence. | Use |
| adolescents; young adults; treatment | Clinical practice guidelines: Depression in adolescents and young adults (2011)* | Beyond Blue (Australia) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 94.4% for scope and purpose, 83.3% for stakeholder involvement, 77.1% for rigour of development, 97.2% for clarity of presentation, 64.6% for applicability, and 75% for editorial independence. | Use |
| adolescents; diagnosis; assessment; treatment | Guidelines for adolescent depression in primary care (GLAD‐PC): I. Identification, assessment, and initial management (2007) | Zuckerbrot, R. A., Cheung, A. H., Jensen, P. S., Stein, R. E. K., Laraqei, D., & GLAD‐PC Steering Group. (2007). Guidelines for adolescent depression in primary care (GLAD‐PC): I. Identification, assessment, and initial management. Pediatrics, 120(5), e12. https://doi.org/10.1542/peds.2007-1144 (Canada and U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 72.2% for scope and purpose, 80.6% for stakeholder involvement, 54.2% for rigour of development, 61.1% for clarity of presentation, 39.6% for applicability, and 50% for editorial independence. | Use with great caution |
| adolescents; treatment | Evidence‐based psychotherapies for depressed adolescents: A review and clinical guidelines (2005) | Gallagher, R. (2005). Evidence‐based psychotherapies for depressed adolescents: A review and clinical guidelines. (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 47.2% for scope and purpose, 38.9% for stakeholder involvement, 9.4% for rigour of development, 25% for clarity of presentation, 12.5% for applicability, and 16.7% for editorial independence. | Do not use |
| adults; diagnosis; treatment | Guía de Práctica Clínica sobre el Manejo de la Depresión en el Adulto (2014) | Guia Salud (Spain) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 100% for scope and purpose, 92% for stakeholder involvement, 60% for rigour of development, 94% for clarity of presentation, 96% for applicability, and 100% for editorial independence. | Use |
| adults; identification; treatment; prevention | The treatment and management of depression in adults (updated edition) National Clinical Practice Guideline 90 (2010) | National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 100% for scope and purpose, 100% for stakeholder involvement, 85% for rigour of development, 100% for clarity of presentation, 40% for applicability, and 100% for editorial independence. | Use with caution |
| adults; non-pharmaceutical; treatment | Non-pharmaceutical management of depression in adults: A national clinical guideline (2010)* | Scottish Intercollegiate Guidelines Network (Scotland) | The guideline was assessed by 3 trained post-graduate level appraisers using the AGREE-II scale (see Medina, J. C., Schmelefske, E., Hébert, C., & Drapeau, M. (2020). European clinical practice guidelines for depression in adults: Are they good enough? Journal of Affective Disorders, 263, 382–385. doi: 10.1016/j.jad.2019.12.005). The guideline obtained a score of 100% for scope and purpose, 93% for stakeholder involvement, 93% for rigour of development, 98% for clarity of presentation, 50% for applicability, and 69% for editorial independence. | Use with caution |
| adults; non-pharmacological treatment | Evidence-based, non-pharmacological treatment guideline for depression in Korea (2014) | Park S-C, Oh HS, Oh D-H, Jung SA, Na K-S, Lee H-Y, et al. Evidence-based, non-pharmacological treatment guideline for depression in Korea. J Korean Med Sci. 2014;29(1):12–22. (Republic of Korea) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 75% for scope and purpose, 47% for stakeholder involvement, 45% for rigour of development, 78% for clarity of presentation, 4% for applicability, and 83% for editorial independence. | Use with great caution |
| adults; screening; improvement of outcome | Screening for depression in primary care: Recommendation statement from the Canadian Task Force on Preventive Health Care (2005) | MacMillan, H. L., Patterson, C. J., Wathen, C. N., and the Canadian Task Force on Preventive Health Care. (2005). Screening for depression in primary care: Recommendation statement from the Canadian Task Force on Preventive Health Care. Canadian Medical Association Journal, 172(1), 33–35. https://doi.org/10.1503/cmaj.1030823 (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 58.3% for scope and purpose, 33.3% for stakeholder involvement, 47.9% for rigour of development, 44.4% for clarity of presentation, 0% for applicability, and 33.3% for editorial independence. | Do not use |
| children; adolescents; assessment; treatment | Practice parameter for the assessment and treatment of children and adolescents with depressive disorders (2007) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 52.8% for scope and purpose, 25% for stakeholder involvement, 40.6% for rigour of development, 69.4% for clarity of presentation, 2.1% for applicability, and 20.8% for editorial independence. | Use with great caution | |
| children; adolescents; treatment | Depression in children and young people: Identification and management (CG 28) (2005) | National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 86.1% for scope and purpose, 75% for stakeholder involvement, 85.4% for rigour of development, 91.7% for clarity of presentation, 70.8% for applicability, and 83.3% for editorial independence. | Use |
| children; adolescents; treatment | The treatment of depressive disorders in children and adolescents (2013) | Dolle, K., & Schulte‐Körne, G. (2013). The treatment of depressive disorders in children and adolescents. Deutsches Ärzteblatt International, 110(50), 854–860. https://doi.org/10.3238/ arztebl.2013.0854 (Germany) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 55.6% for scope and purpose, 41.7% for stakeholder involvement, 62.5% for rigour of development, 77.8% for clarity of presentation, 16.7% for applicability, and 37.5% for editorial independence. | Use with caution |
| children; adolescents; treatment | Treatment of depression in children and adolescents (2005) | Bostic, J. Q., Rubin, D. H., Prince, J., & Schlozman, S. (2005). Treatment of depression in children and adolescents. Journal of Psychiatric Practice, 11(3), 141–154. Retrieved from https://www.ncbi.nlm.nih.gov/ pubmed/15920388 (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 36.1% for scope and purpose, 16.7% for stakeholder involvement, 15.6% for rigour of development, 61.1% for clarity of presentation, 6.3% for applicability, and 0% for editorial independence. | Use with great caution |
| children; pharmacological treatment | Texas children's medication algorithm project: Update from Texas consensus conference panel on medication treatment of childhood major depressive disorder (2007) | Hughes, C. W., Emslie, G. J., Crismon, M. L., Posner, K., Birmaher, B., Ryan, N. … Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder (2007). Texas children's medication algorithm project: Update from Texas consensus conference panel on medication treatment of childhood major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(6), 667–686. https://doi.org/10.1097/ chi.0b013e31804a859b (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 69.4% for scope and purpose, 55.6% for stakeholder involvement, 22.9% for rigour of development, 75% for clarity of presentation, 18.8% for applicability, and 58.3% for editorial independence. | Use with great caution |
| different populations; treatment | Depression: MOH clinical practice guidelines (2012) | Singapore Ministry of Health (Singapore) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 58.3% for scope and purpose, 72.2% for stakeholder involvement, 37.5% for rigour of development, 80.6% for clarity of presentation, 39.6% for applicability, and 0% for editorial independence. | Use with great caution |
Depression and Acupuncture
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| general population; acupuncture treatment; Chinese medicine | Clinical practice guidelines for using acupuncture to treat depression (2015) | Zhao H, Sun YX, Luo HC, Guo X, Zi MJ, Liu J, et al. Clinical practice guidelines for using acupuncture to treat depression. Chin J Integr Med. 2015. (China) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 100% for scope and purpose, 67% for stakeholder involvement, 48% for rigour of development, 89% for clarity of presentation, 38% for applicability, and 8% for editorial independence. | Use with great caution |
Depression and Anxiety
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; antidepressant medication treatment | Clinical guidance on the use of antidepressant medications in children and adolescents (2005) | Lyndon, B., Rowe, L., Fraser, A., Efron, D., Walter, G., Wilson, I. … Royal Australian College of General Practitioners. (2005). Clinical guidance on the use of antidepressant medications in children and adolescents. Australian Family Physician, 34(9), 77 (Australia) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 44.4% for scope and purpose, 38.9% for stakeholder involvement, 7.3% for rigour of development, 52.8% for clarity of presentation, 0% for applicability, and 0% for editorial independence. | Do not use |
| children; adolescents; diagnosis; intervention; treatment | Anxiety and depression in children and youth—Diagnosis and treatment (2010) | Guidelines & Protocols Advisory Committee (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 41.7% for scope and purpose, 8.3% for stakeholder involvement, 15.6% for rigour of development, 55.6% for clarity of presentation, 27.1% for applicability, and 0% for editorial independence. | Do not use |
| children; adolescents; SSRI treatment | 2008 position paper on using SSRIs in children and adolescents (2009) | Garland, E. J., Kutcher, S., & Virani, A. (2009). 2008 position paper on using SSRIs in children and adolescents. Journal of Child Psychology and Psychiatry, 18(2), 160–165. (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 50% for scope and purpose, 27.8% for stakeholder involvement, 27.1% for rigour of development, 55.6% for clarity of presentation, 16.7% for applicability, and 0% for editorial independence. | Do not use |
Depressive Disorders
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| definition; management; treatment | Clinical Practice Guidelines for the Treatment of Depressive Disorders (2001) | Canadian Psychiatric Association (Canada) | The guideline was assessed by three trained Master-level researchers using the AGREE-II scale (see Middleton, J. C., Kalogeropoulos, C., Middleton, J. A., & Drapeau, M. (2018). Assessing the methodological quality of the Canadian Psychiatric Associations anxiety and depression clinical practice guidelines. Journal of Evaluation in Clinical Practice. doi:10.1111/jep.13026). The guideline obtained a score of 94% for scope and purpose, 52% for stakeholder involvement, 57% for rigour of development, 91% for clarity of presentation, 22% for applicability, and 36% for editorial independence. | Use with great caution |
Developmental Delay in Children Not Yet Eligible for Preschool
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| assessment; child; preschool; education; developmental delay; rehabilitation; adaptation | Évaluer un enfant qui n'est pas encore admissible à l'éducation préscolaire et qui présente des indices de retard de développement dans le but de déterminer des services de réadaptation et d'adaptation répondant à ses besoins (2011) | Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 93% for scope and purpose, 58% for stakeholder involvement, 16% for rigour of development, 83% for clarity of presentation, 28% for applicability, and 0% for editorial independence. | Use with great caution |
Disruptive Behaviour Disorders
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; diagnosis; assessment; treatment | Disruptive Behaviors in Children and Adolescents (2014) | University of Arkansas for Medical Sciences - Psychiatric Research Institute (U.S.A) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 30.6% for scope and purpose, 5.6% for stakeholder involvement, 17.7% for rigour of development, 44.4% for clarity of presentation, 20.8% for applicability, and 16.7% for editorial independence. | Do not use |
Driving Aptitude Examination
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| driving; occupational therapy; motor vehicle | L’évaluation médicale de l’aptitude à conduire un véhicule automobile- Guide d'exercice (2007) | Collège des médecins du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 78% for scope and purpose, 47% for stakeholder involvement, 3% for rigour of development, 69% for clarity of presentation, 19% for applicability, and 0% for editorial independence. | Use with great caution |
Dyslexia
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| evaluation; children | Lignes Directrices pour l'évaluation de la dyslexie chez les enfants (2014) or Guidelines for the Evaluation of Dyslexia in Children (2014) | Ordre des Psychologues du Québec (Canada) |
The guideline was assessed by 3 trained raters using the AGREE-II scale (see Trepanier, L., Stamoulos, C., & Reyes, A. (2017). Assessing the quality of the OPQ’s Guidelines for the Evaluation of Dyslexia in Children using the Appraisal of Guidelines for Research and Evaluation (AGREE) II: A brief report. Canadian Psychology/Psychologie Canadienne, 58(3), 211-217. doi:10.1037/cap0000121). The guideline obtained a score of 100% for scope and purpose, 59% for stakeholder involvement, 51% for rigour of development, 65% for clarity of presentation, 28% for applicability, and 0% for editorial independence. The guideline was also assessed by another team consisting of 4 trained assessors from the Science and Practice in Psychology Research Group using a method derived from Ansari & Rachidian (2012) (see Stamoulos, C., Reyes, A., Trepanier, L., & Drapeau, M. (2014). The methodological quality of clinical practice guidelines in psychology: A pilot study of the guidelines developed by the Ordre des Psychologues du Québec. Canadian Psychology/Psychologie Canadienne, 55(3), 177–186. doi: 10.1037/a0037287). The guideline was found to not meet the minimum quality requirements for the 27 tasks related to proper guideline development. |
Use with great caution |
Electronic Communications
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| best practices | Guidelines for Best Practices in Electronic Communications (2015) | Ontario Psychological Association (OPA) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 94% for scope and purpose, 33% for stakeholder involvement, 25% for rigour of development, 61% for clarity of presentation, 21% for applicability, and 0% for editorial independence. | Use with great caution |
Evaluation of Adjustment Difficulties
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| psychoeducational evaluation; adjustment difficulties; adaptive capacity | L’évaluation psychoéducative de la personne en difficulté d'aptation (2010) | Ordre des psychoéducateurs et psychoéducatrices du Québec (Canada) | The guideline was assessed by four trained bilingual graduate students using the AGREE-II scale (see Ciquier, G., Azzi, M., Hébert, C., Watkins‐Martin, K., & Drapeau, M. (2020). Assessing the quality of seven clinical practice guidelines from four professional regulatory bodies in Quebec: What's the verdict? Journal of Evaluation in Clinical Practice, 1–9. doi: 10.1111/jep.13374). The guideline obtained a score of 90% for scope and purpose, 54% for stakeholder involvement, 8% for rigour of development, 64% for clarity of presentation, 14% for applicability, and 0% for editorial independence. | Use with great caution |
Evaluation of Driving Ability
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| evaluation; ergotherapy; interventions regarding use of automobile | Interventions relatives à l’utilisation d’un véhicule routier (2008) | Ordre des ergothérapeutes du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 100% for scope and purpose, 69% for stakeholder involvement, 18% for rigour of development, 89% for clarity of presentation, 36% for applicability, and 15% for editorial independence. | Use with great caution |
Exercise for People with Cancer
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| cancer; exercise; adults; recommendations | Exercise for People with Cancer (2015) | Cancer Care Ontario (Canada) | The guideline was assessed by 3 trained graduate students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 97% for scope and purpose, 61% for stakeholder involvement, 94% for rigour of development, 81% for clarity of presentation, 25% for applicability, and 81% for editorial independence. | Use with caution |
General Counselling for Youth
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| orientation; counselling; students; youth | Guide de pratique – Orientation en formation générale des jeunes (2010) | Ordre des conseillers et conseillères d'orientation du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 93% for scope and purpose, 67% for stakeholder involvement, 13% for rigour of development, 78% for clarity of presentation, 38% for applicability, and 0% for editorial independence. | Use with great caution |
Guidelines for School Psychologists
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| school psychology; roles and responsibilities of school psychologists; access and referral to school psychologists | Professional Practice Guidelines for School Psychologists in Ontario (2013) | Ontario Psychological Association (OPA) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 78% for scope and purpose, 39% for stakeholder involvement, for 19% for rigour of development, 78% for clarity of presentation, 17% for applicability, and 0% for editorial independence. | Use with great caution |
Heart Disease and Attention Deficit Hyperactivity Disorder Medication
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; heart disease; children and adolescents; cardiovascular monitoring | Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity Disorder (2008) | Vetter, V. L., Elia, J., Erickson, C., Berger, S., Blum, N., Uzark, K., & Webb, C. L. (2008). Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder. A Scientific Statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing, 117(18), 2407–2423. https://doi.org/10.1161/ circulationaha.107.189473. (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 58.3% for scope and purpose, 33.3% for stakeholder involvement, 39.6% for rigour of development, 63.9% for clarity of presentation, 20.8% for applicability, and 58.3% for editorial independence. | Use with great caution |
Intellectual Disability
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| mental retardation; evaluation | Lignes directrices pour l'évaluation du retard mental (2007) or Guidelines for the Evaluation of Mental Retardation (2007) | Ordre des Psychologues du Québec (Canada) |
The guideline was assessed by a research team from the Science and Practice in Psychology Research Group trained using the AGREE-II scale (Unpublished data). The guideline obtained a score of 91% for scope and purpose, 44% for stakeholder involvement, 19% for rigour of development, 81% for clarity of presentation, 13% for clarity of presentation, and 0% for editorial independence. The guideline was also assessed by another team consisting of 4 trained assessors from the Science and Practice in Psychology Research Group using a method derived from Ansari & Rachidian (2012) (see Stamoulos, C., Reyes, A., Trepanier, L., & Drapeau, M. (2014). The methodological quality of clinical practice guidelines in psychology: A pilot study of the guidelines developed by the Ordre des Psychologues du Québec. Canadian Psychology/Psychologie Canadienne, 55(3), 177–186. doi: 10.1037/a0037287). The guideline was found to not meet the minimum quality requirements for the 27 tasks related to proper guideline development. |
Use with great caution |
Interventions in Youth Centres
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| intervention; youth centre; mental health; suicidal risk | Déterminer un plan d’intervention pour une personne atteinte d’un trouble mental ou présentant un risque suicidaire qui est hébergée dans une installation d’un établissement qui exploite un centre de réadaptation pour les jeunes en difficulté d’adaptation (2014) | Ordre des psychoéducateurs et psychoéducatrices du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 90% for scope and purpose, 64% for stakeholder involvement, 9% for rigour of development, 69% for clarity of presentation, 10% for applicability, and 0% for editorial independence. | Use with great caution |
Major Depressive Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; screening | Best evidence statement (BESt): Screening of children and adolescents for major depressive disorder (MDD) (2010)* | Cincinnati Children's Hospital Medical Center (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 69.4% for scope and purpose, 38.9% for stakeholder involvement, 42.7% for rigour of development, 63.9% for clarity of presentation, 33.3% for applicability, and 0% for editorial independence. | Use with great caution |
| children; adolescents; treatment | Best evidence statement (BESt): Treatment of children and adolescents with major depressive disorder (MDD) during the acute phase (2010)* | Cincinnati Children's Hospital Medical Center (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 72.2% for scope and purpose, 38.9% for stakeholder involvement, 44.8% for rigour of development, 86.1% for clarity of presentation, 39.6% for applicability, and 0% for editorial independence. | Use with great caution |
| MDD; adults; treatment | Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: introduction and methods (2016) | Canadian Network for Mood and Anxiety Treatments (Canada) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 92% for scope and purpose, 67% for stakeholder involvement, 53% for rigour of development, 83% for clarity of presentation, 0% for applicability, and 100% for editorial independence. | Use with great caution |
| MDD; adults; treatment | Practice guideline for the treatment of patients with major depressive disorder third edition (2010) | American Psychiatric Association (U.S.A.) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 94% for scope and purpose, 64% for stakeholder involvement, 55% for rigour of development, 89% for clarity of presentation, 15% for applicability, and 100% for editorial independence. | Use with great caution |
| MDD; children; adolescents; screening; treatment | Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement (2009) | US Preventive Services Task Force (USA) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 86.1% for scope and purpose, 33.3% for stakeholder involvement, 71.9% for rigour of development, 69.4% for clarity of presentation, 14.6% for applicability, and 79.2% for editorial independence. | Use with caution |
| MDD; general population; treatment | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary (2018) | Royal Australian and New Zealand College of Psychiatrists (Australia and New Zealand) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 100% for scope and purpose, 81% for stakeholder involvement, 59% for rigour of development, 100% for clarity of presentation, 8% for applicability, and 100% for editorial independence. | Use with great caution |
| MDD; general population; treatment | The Korean medication algorithm for depressive disorder: Second revision (2014) | Seok Seo, J., Rim Song, H., Bin Lee, H., Park, Y. M., Hong, J. W., Kim, W., … Bahk, W. M. (2014). The Korean medication algorithm for depressive disorder: Second revision. Journal of Affective Disorders, 167, 312–321. https://doi.org/10.1016/j.jad.2014.05 (Korea) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 33.3% for scope and purpose, 19.4% for stakeholder involvement, 22.9% for rigour of development, 25% for clarity of presentation, 0% for applicability, and 50% for editorial independence. | Do not use |
Major Depressive Disorder in Veterans
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| MDD; adults; VA/DoD (Veterans Administration/Department of Defense); assessment; treatment; management | VA/DoD clinical practice guideline for the management of major depressive disorder (2016) | U.S. Department of Veterans Affairs (U.S.A.) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 94% for scope and purpose, 86% for stakeholder involvement, 78% for rigour of development, 100% for clarity of presentation, 17% for applicability, and 100% for editorial independence. | Use with caution |
Mental Disorder or Suicidal Risk in Youth Centre
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| intervention; youth rehabilitation; mental health; suicidal risk | Déterminer un plan d'intervention pour une personne atteinte d'un trouble mental ou présentant un risque suicidaire qui est hébergée dans une installation d'un établissement qui exploite un centre de réadaptation pour les jeunes en difficulté d'adaptation (2012) | Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 97% for scope and purpose, 56% for stakeholder involvement, 17% for rigour of development, 36% for clarity of presentation, 6% for applicability, and 0% for editorial independence. | Use with great caution |
Mood and Anxiety Disorder Comorbidity
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| general population; treatment | The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders (2012) | Schaffer, A., McIntosh, D., Goldstein, B. I., Rector, N. A., McIntyre, R. S., Beaulieu, S. … Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. (2012). The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Annals of Clinical Psychiatry, 24(1), 6–22. (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 44.4% for scope and purpose, 22.2% for stakeholder involvement, 32.3% for rigour of development, 66.7% for clarity of presentation, 0% for applicability, and 25% for editorial independence. | Use with great caution |
Oppositional Defiant Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ODD; children; adolescents; assessment; treatment | Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder (2007) | Steiner, H., & Remsing, L. (2007). Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(1), 126–141. (U.S.A.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 41.7% for scope and purpose, 36.1% for stakeholder involvement, 27.1% for rigour of development, 61.1% for clarity of presentation, 0% for applicability, and 12.5% for editorial independence. | Use with great caution |
Pharmacotherapy for Attention Deficit Hyperactivity Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; children; pharmacological treatment; comorbidity | The Texas Children’s Medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder (2006) | Pliszka, S. R., Crismon, M. L., Hughes, C. W., Corners, C. K., Emslie, G. J., Jensen, P. S., … Lopez, M. (2006). The Texas Children’s Medication algorithm project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 33.3% for scope and purpose, 52.8% for stakeholder involvement, 22.9% for rigour of development, 61.1% for clarity of presentation, 31.3% for applicability, and 25% for editorial independence. | Use with great caution |
Pharmacotherapy of Depression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| adults; pharmacological treatment | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults: III. Pharmacoptherapy. (2009) | Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R. et al. (2009). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy Journal of affective disorders, 117, S26–S43. https://doi.org/10.1016/j.jad.2009.06.041 (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 58.3% for scope and purpose, 36.1% for stakeholder involvement, 47.9% for rigour of development, 63.9% for clarity of presentation, 0% for applicability, and 58.3% for editorial independence. | Use with great caution |
Professional Boundaries
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| healthcare practice; recognizing problem situations; strategies to manage boundaries | Professional Boundaries in Healthcare Relationships (2017) | College of Psychologists of Ontario (CPO) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 89% for scope and purpose, 33% for stakeholder involvement, 8% for rigour of development, 78% for clarity of presentation, 13% for applicability, and 0% for editorial independence. | Use with great caution |
Restraining and Isolation
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| intervention; restraint; isolation; social workers; Cree First Nation | Décider de l'utilisation des mesures de contention et d'isolement dans le cadre de la Loi sur les services de santé et des services sociaux pour les autochtones cris (2011) | Ordre des travailleurs sociaux et thérapeutes conjugaux et familiaux du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 83% for scope and purpose, 58% for stakeholder involvement, 19% for rigour of development, 79% for clarity of presentation, 22% for applicability, and 0% for editorial independence. | Use with great caution |
School Admission Derogation
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| evaluation; derogation; children; assessment | Lignes directrices pour l'évaluation d'un enfant en vue d'une demande de dérogation à l'âge d'admission à l'école (2006) or Guidelines for the Assessment of a Child in Connection with a Request for Derogation to the Age of School Admission (2006) | Ordre des Psychologues du Québec (Canada) |
The guideline was assessed by a research team from the Science and Practice in Psychology Research Group trained using the AGREE-II scale (Unpublished data). The guideline obtained a score of 81% for scope and purpose, 39% for stakeholder involvement, 17% for rigour of development, 67% for clarity of presentation, 6% for applicability, and 3% for editorial independence. The guideline was also assessed by another team consisting of 4 trained assessors from the Science and Practice in Psychology Research Group using a method derived from Ansari & Rachidian (2012) (see Stamoulos, C., Reyes, A., Trepanier, L., & Drapeau, M. (2014). The methodological quality of clinical practice guidelines in psychology: A pilot study of the guidelines developed by the Ordre des Psychologues du Québec. Canadian Psychology/Psychologie Canadienne, 55(3), 177–186. doi: 10.1037/a0037287). The guideline was found to not meet the minimum quality requirements for the 27 tasks related to proper guideline development. |
Use with great caution |
Screening for Depression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| adults; benefits and harms of screening for depression | Screening for depression in adults: an updated systematic evidence review for the US preventive services task force (2016) | US Preventive Services Task Force (U.S.A.) | The guideline was assessed by 2 researchers using the AGREE-II scale (see Zafra-Tanaka, J. H., Goicochea-Lugo, S., Villarreal-Zegarra, D., & Taype-Rondan, A. (2019). Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2057-z). The guideline obtained a score of 94% for scope and purpose, 53% for stakeholder involvement, 65% for rigour of development, 86% for clarity of presentation, 17% for applicability, and 100% for editorial independence. | Use with caution |
Sexual Abuse by Healthcare Workers
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| prevention; sexual abuse of clients by healthcare professionals; mandatory reporting | Prevention of Sexual Abuse of Clients and Mandatory Reporting (2017) | College of Psychologists of Ontario (CPO) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 44% for scope and purpose, 44% for stakeholder involvement, 2% for rigour of development, 50% for clarity of presentation, 13% for applicability, and 0% for editorial independence. | Do not use |
Social Anxiety
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| general population; assessment; treatment | Social anxiety disorder: The NICE guideline on recognition, assessment and treatment, (CG 159) (2013) | National Institute for Health and Care Excellence (U.K.) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist and a methodologist) using the AGREE-II scale (see Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540. doi:10.1002/da.22752). The guideline obtained a score of 86.1% for scope and purpose, 86.1% for stakeholder involvement, 77.1% for rigour of development, 77.8% for clarity of presentation, 70.8% for applicability, and 91.7% for editorial independence. | Use |
Stimulant Medication Risk for Attention Deficit Hyperactivity Disorder
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| ADHD; children; youth; cardiac risk assessment and use of stimulant medication | Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry (2009) | Hamilton, R., Gray, C., Bélanger, S. A., Warren, A. E., Gow, R. M., Sanatani, S., … Schachar, R. (2009). Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 18(4), 349–355. (Canada) | The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 52.8% for scope and purpose, 52.8% for stakeholder involvement, 33.3% for rigour of development, 50% for clarity of presentation, 20.8% for applicability, and 0% for editorial independence. | Do not use |
Telemedicine
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| medicine; distance | Le médecin, la télémédecine et les technologies de l'information et de la communication (2015) | Collège des médecins du Québec (Canada) | The guideline was assessed by four trained appraisers using the AGREE-II scale (see Hébert, C., Watkins-Martin, K., Ciquier, G., Azzi, M., & Drapeau, M. (2020). The quality of clinical practice guidelines in health and social sciences: are we on the right track?. Manuscript submitted for publication). The guideline obtained a score of 75% for scope and purpose, 58% for stakeholder involvement, 10% for rigour of development, 76% for clarity of presentation, 15% for applicability and 0% for editorial independence. | Use with great caution |
Telepsychology
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| best practices | Guidelines for Best Practices in the Provision of Telepsychology (2015) | Ontario Psychological Association (OPA) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 83% for scope and purpose, 28% for stakeholder involvement, 15% for rigour of development, 100% for clarity of presentation, 17% for applicability, and 0% for editorial independence. | Use with great caution |
Use of Social Media by Professionals
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| best practices | Guidelines for Best Practices in the Use of Social Media (2015) | Ontario Psychological Association (OPA) (Canada) | The guideline was assessed by 3 trained doctoral students from the Science and Practice in Psychology Research Group using the AGREE-II scale (Unpublished data). The guideline obtained a score of 67% for scope and purpose, 22% for stakeholder involvement, 17% for rigour and development, 72% for clarity of presentation, 38% for applicability, and 0% for editorial independence. | Use with great caution |
Youth Aggression
| Keywords | Title of Guideline | Organization/Authors (Country) | Summary | Recommendation |
|---|---|---|---|---|
| children; adolescents; diagnosis; assessment; management; treatment; family engagement | Treatment of Maladaptive Aggression in Youth: CERT Guidelines I. Engagement, Assessment, and Management (2012) | Knapp, P., Chait, A., Pappadopulos, E., Crystal, S., & Jensen, P. S. (2012). Treatment of maladaptive aggression in youth: CERT guidelines I. Engagement, assessment, and management. Pediatrics, 129(6), e1562–e1576. https://doi.org/ 10.1542/peds.2010-1360. (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 69.4% for scope and purpose, 61.1% for stakeholder involvement, 50% for rigour of development, 58.3% for clarity of presentation, 27.1% for applicability, and 54.2% for editorial independence. | Use with great caution |
| children; adolescents; management; psychosocial treatment; pharmacological treatment; side-effect management | Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management (2012) | Scotto Rosato, N., Correll, C. U., Pappadopulos, E., Chait, A., Crystal, S., & Jensen, P. S. (2012a). Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management. Pediatrics, 129(6), e1577–e1586. https://doi.org/10.1542 /peds.2010-1361 (U.S.A.) |
The guideline was assessed by 2 trained reviewers (a child & adolescent psychiatrist, and a methodologist) as well as 2 psychology post-doctoral fellows using the AGREE-II scale (see Andrade, B. F., Courtney, D., Duda, S., Aitken, M., Craig, S. G., Szatmari, P., . . . Bennett, K. (2019). A Systematic Review and Evaluation of Clinical Practice Guidelines for Children and Youth with Disruptive Behavior: Rigor of Development and Recommendations for Use. Clinical Child and Family Psychology Review, 1-22. doi:10.1007/s10567-019-00292-2). The guideline obtained a score of 63.9% for scope and purpose, 61.1% for stakeholder involvement, 58.3% for rigour of development, 72.2% for clarity of presentation, 29.2% for applicability, and 58.3% for editorial independence. | Use with great caution |
Content last reviewed: Sept, 2020
